Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 46, 8-13, January 1, 1986]
© 1986 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fleischmann, W. R.
Right arrow Articles by Gindhart, T. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fleischmann, W. R., Jr.
Right arrow Articles by Gindhart, T. D.

Effect of Hyperthermia on the Antiproliferative Activities of Murine {alpha}-, ß-, and {gamma}-Interferon: Differential Enhancement of Murine {gamma}-Interferon1

W. Robert Fleischmann, Jr.2, Christina M. Fleischmann and Thomas D. Gindhart

Department of Microbiology, The University of Texas Medical Branch, Galveston, Texas 77550 [W. R. F., C. M. F.], and Laboratory of Experimental Pathology, National Cancer Institute, Frederick Cancer Research Facility, Frederick, Maryland 21701 [T. D. G.]

Fever is frequently an important side effect of interferon (IFN) therapy. Studies have shown that culturing interferon-treated cells at elevated temperature heightens the antiproliferative activity of IFN-{alpha} and IFN-ß. Since IFN-{gamma} has also been shown to be a potent antiproliferative agent, the effect of elevated temperature on IFN-{gamma} activity was compared to its effect on IFN-{alpha} and IFN-ß. Mouse B-16 melanoma cells were simultaneously cultured under cloning conditions at a range of temperatures (37.3, 38.1, 38.6, and 39.4°C) in the presence of MuIFN-{alpha}, MuIFN-ß, and MuIFN-{gamma}. The antiproliferative activities of all three interferons were enhanced by incubation at the elevated temperatures. However, the elevated temperatures had a more dramatic enhancing effect on the antiproliferative activity of MuIFN-{gamma} (10-fold enhancement) than of either MuIFN-{alpha} or MuIFN-ß (2.9- and 3.4-fold enhancement, respectively). Next, the enhancing effect of elevated temperature (39.4°C) was examined for a range of interferon concentrations. The degree of the enhancing effect increased with increasing concentrations of MuIFN-{gamma} but not with increasing concentrations of MuIFN-{alpha} or MuIFN-ß. Enhancing effects of temperature as high as 14-fold were observed for 100 units of MuIFN-{gamma}/ml. This dramatic enhancement was observed for both natural and recombinant MuIFN-{gamma} and was neither a function of greater relative perception of MuIFN-{gamma} titer at elevated temperature nor a function of greater relative stability of MuIFN-{gamma} at the elevated temperature. The differential enhancement of MuIFN-{gamma} activity by elevated temperature appeared to be specific for the antiproliferative activity, since the antiviral activity of MuIFN-{gamma} was not relatively more enhanced at 39.4°C than were the antiviral activities of MuIFN-{alpha} and MuIFN-ß. These results suggest that fever may be an important factor in maximizing the antitumor effects of MuIFN-{gamma} and perhaps of human IFN-{gamma}. They also raise the possibility that a combination treatment regimen of hyperthermia and interferon therapy, particularly IFN-{gamma} therapy, may provide a significant antitumor effect.

1 Supported by USPHS Grant CA26475 awarded by the National Cancer Institute, Department of Health and Human Services.

2 To whom requests for reprints should be addressed, at Department of Microbiology, The University of Texas Medical Branch, Galveston, TX 77550.

Received 4/18/85. Revised 9/ 3/85. Accepted 9/16/85.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1986 by the American Association for Cancer Research.